Swiss National Bank Portfolio holdings
The Swiss National Bank (SNB), founded in 1907 and headquartered in Zurich with an office in Bern, is Switzerland’s central bank, responsible for conducting monetary policy, issuing the Swiss franc, and ensuring price stability, while uniquely managing a massive investment portfolio. Unlike most central banks, the SNB is a joint-stock company with shares traded on the SIX Swiss Exchange, owned roughly 55% by public entities like cantons and 45% by private investors, yet it operates independently under federal oversight. It holds over $800 billion in foreign currency reserves as of late 2024—invested in global equities, bonds, and gold—to manage the franc’s value, famously intervening in markets to prevent excessive appreciation, as seen with the 2015 abandonment of the euro peg. Led by Chairman Thomas Jordan until his planned exit in September 2024, the SNB balances its dual role as a monetary authority and a significant global investor, influencing both Swiss and international financial stability.
Top Buys
| 1 |
Alibaba
BABA
|
+$138M |
| 2 |
AbbVie
ABBV
|
+$122M |
| 3 |
Zoom
ZM
|
+$109M |
| 4 |
Amazon
AMZN
|
+$105M |
| 5 |
Regeneron Pharmaceuticals
REGN
|
+$103M |
Top Sells
| 1 |
AGN
Allergan plc
AGN
|
+$226M |
| 2 |
RTN
Raytheon Company
RTN
|
+$145M |
| 3 |
Newmont
NEM
|
+$52.9M |
| 4 |
WBC
WABCO HOLDINGS INC.
WBC
|
+$51.2M |
| 5 |
Yum! Brands
YUM
|
+$34.4M |
Sector Composition
| 1 | Technology | 25.6% |
| 2 | Healthcare | 15.16% |
| 3 | Consumer Discretionary | 12.49% |
| 4 | Communication Services | 10.4% |
| 5 | Industrials | 8.06% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
2126
Castle Biosciences
CSTL
$621M
| $965K | ﹤0.01% |
+25,600
| New | +$965K |
|
|
ECOM
2127
DELISTED
CHANNELADVISOR CORPORATION
ECOM
| $965K | ﹤0.01% |
60,900
+10,000
| +20% | +$158K |
|
|
AGEN
2128
Agenus
AGEN
$143M
| $964K | ﹤0.01% |
12,498
+1,111
| +10% | +$85.7K |
|
2129
Monarch Casino & Resort
MCRI
$1.9B
| $961K | ﹤0.01% |
28,211
+3,700
| +15% | +$126K |
|
2130
First Financial Corporation Common Stock
THFF
$691M
| $959K | ﹤0.01% |
26,026
+5,000
| +24% | +$184K |
|
2131
Liberty Latin America Class A
LILA
$1.5B
| $953K | ﹤0.01% |
103,978
+13,687
| +15% | +$125K |
|
2132
National Presto Industries
NPK
$802M
| $953K | ﹤0.01% |
10,900
+1,400
| +15% | +$122K |
|
|
ATRS
2133
DELISTED
Antares Pharma, Inc.
ATRS
| $952K | ﹤0.01% |
346,100
+45,400
| +15% | +$125K |
|
2134
Chefs' Warehouse
CHEF
$2.7B
| $948K | ﹤0.01% |
69,800
+19,800
| +40% | +$269K |
|
2135
Garrett Motion
GTX
$2.64B
| $946K | ﹤0.01% |
170,800
+25,700
| +18% | +$142K |
|
|
DBD
2136
DELISTED
Diebold Nixdorf Incorporated
DBD
| $944K | ﹤0.01% |
155,759
+14,300
| +10% | +$86.7K |
|
|
KBAL
2137
DELISTED
Kimball International
KBAL
| $944K | ﹤0.01% |
81,700
+10,500
| +15% | +$121K |
|
2138
E.W. Scripps
SSP
$257M
| $943K | ﹤0.01% |
107,816
+14,200
| +15% | +$124K |
|
|
MEET
2139
DELISTED
The Meet Group, Inc. Common Stock
MEET
| $942K | ﹤0.01% |
+151,000
| New | +$942K |
|
2140
Tredegar Corp
TG
$279M
| $938K | ﹤0.01% |
60,900
+9,200
| +18% | +$142K |
|
2141
InMode
INMD
$937M
| $935K | ﹤0.01% |
+66,000
| New | +$935K |
|
|
AD
2142
Array Digital Infrastructure, Inc.
AD
$4.41B
| $935K | ﹤0.01% |
30,300
+4,600
| +18% | +$142K |
|
2143
Peoples Bancorp
PEBO
$1.08B
| $934K | ﹤0.01% |
43,900
+5,800
| +15% | +$123K |
|
2144
NexGen Energy
NXE
$4.36B
| $933K | ﹤0.01% |
720,400
+131,800
| +22% | +$171K |
|
2145
Eventbrite
EB
$262M
| $933K | ﹤0.01% |
108,900
+14,300
| +15% | +$123K |
|
|
MSGN
2146
DELISTED
MSG Networks Inc.
MSGN
| $931K | ﹤0.01% |
93,600
+7,900
| +9% | +$78.6K |
|
2147
Hawkins
HWKN
$3.62B
| $928K | ﹤0.01% |
43,588
+6,800
| +18% | +$145K |
|
2148
Amneal Pharmaceuticals
AMRX
$3.14B
| $926K | ﹤0.01% |
194,500
-13,600
| -7% | -$64.7K |
|
2149
Heidrick & Struggles
HSII
$1.03B
| $925K | ﹤0.01% |
42,800
+5,600
| +15% | +$121K |
|
2150
VirnetX
VHC
$74.7M
| $925K | ﹤0.01% |
+7,115
| New | +$925K |
|